Congenital ichthyosiform erythroderma due to a CYP4F22 mutation responds to ustekinumab: A case report and review of the literature
- 7 October 2022
- journal article
- letter
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (3) , E389-E391
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Congenital ichthyosiform erythroderma with a novel variant inABCA12in a Chinese patientPediatric Investigation, 2020
- Successful treatment of Netherton syndrome with ustekinumab in a 15‐year‐old girlBritish Journal of Dermatology, 2020
- Autosomal recessive congenital ichthyosis due to homozygous variants in NIPAL4 with a dramatic response to ustekinumabPediatric Dermatology, 2019
- Novel DSP Spectrin 6 Region Variant Causes Neonatal Erythroderma, Failure to Thrive, Severe Herpes Simplex Infections and Brain LesionsActa Dermato-Venereologica, 2019
- Genotype–phenotype correlation in a large English cohort of patients with autosomal recessive ichthyosisBritish Journal of Dermatology, 2019
- Ichtyoses congénitales : les biothérapies aussi ?Annales de Dermatologie et de Vénéréologie, 2018
- The spectrum of manifestations in desmoplakin gene (DSP) spectrin repeat 6 domain mutations: Immunophenotyping and response to ustekinumabJournal of the American Academy of Dermatology, 2018
- An IL-17–dominant immune profile is shared across the major orphan forms of ichthyosisJournal of Allergy and Clinical Immunology, 2017
- Revised nomenclature and classification of inherited ichthyoses: Results of the First Ichthyosis Consensus Conference in Sorèze 2009Journal of the American Academy of Dermatology, 2010